Chang Gung University, Taiwan, Joins Waters Centers of Innovation Program
The Taipei’s Chang Gung University (CGU) Healthy Aging Research Center has joined the Waters Centers of Innovation (COI) Program as a partner, making it the first in Taiwan to do so.
The Taipei’s Chang Gung University (CGU) Healthy Aging Research Center has joined the Waters Centers of Innovation (COI) Program as a partner, making it the first in Taiwan to do so.
Led by Dr. Daniel Tsun-Yee Chiu, Dean of Research & Development, and director of CGU’s Healthy Aging Research Center, the Center focuses on investigating the mechanisms of disease, particularly in the elderly. Chiu has a special interest in the effects of oxidative stress on cellular function and establishing reference laboratories to assess oxidative stress and antioxidant capacity in health and in diseases. He is currently the president of the Society of Free Radical Research-Asia and he has published over 140 scientific articles in this area.
Dr. Chiu said: “We are truly honoured to become Waters Corporation’s COI partner in Taiwan. I am confident that the research conducted with the assistance of Waters’ technology will lead to breakthroughs that will greatly advance the study of various degenerative diseases and their impact on human health. I would like to once more extend our thanks to Waters for their recognition of our research.”
Attending the ceremony was Dean Yu, General Manager of Waters Taiwan, who extended his congratulations on behalf of Waters to Dr. Chiu and his team. Yu said: “Dr. Chiu and his colleague, Professor Ming-Shi Shiao, have been advocates, technical advisors, and pioneers in the field of metabolomics, metabolite I.D. and profiling in Taiwan for many years. Their considerable influence within CGU, as well as other major Taiwanese and international institutes, is well deserved. On behalf of all Waters employees, we are excited that Chiu’s team is now a Waters COI partner."
Presenting GC Data Comparisons to Laypersons to Understand Potential Courtroom Implications
January 6th 2025In forensic science, scientific testimony is routinely presented in court to juries who may have limited or no scientific background, putting law enforcement and defense personnel in the position of having to make rapid decisions in short timeframes based on findings of which they are not specialists. Katelynn Perrault Uptmor, Assistant Professor of Chemistry at William & Mary (Williamsburg, Virginia) believes that the introduction of new technologies into the framework of routine forensic analysis must therefore bridge the gap between introduction of new and novel analytical science and the communication of that science to a court of law, and that analytical chemistry research must be mindful of the need to fill this gap in promoting new technologies.
Detailed Glycosylation Analysis of Therapeutic Enzymes Utilizing Comprehensive 2D-LC–MS
January 3rd 2025In this article, the use of comprehensive two-dimensional liquid chromatography (LC×LC) coupled to mass spectrometry (MS) for characterizing glycosylation of therapeutic enzymes is presented.
Advancing Gene Therapy: Enzyme Selection for Effective RNA Oligonucleotide Mapping
New gene therapy modalities, such as CRISPR guide RNA (single guide ribonucleic acid [sgRNA]) and messenger RNA (mRNA), continue to make progress in both primate and first-in-human trials. As this progress builds, the industry remains accountable for characterizing these molecules to meet the requirements of regulatory authorities.
